U.S. Markets close in 2 hrs 9 mins
  • S&P 500

    4,549.78
    0.00 (0.00%)
     
  • Dow 30

    35,697.02
    +93.94 (+0.26%)
     
  • Nasdaq

    15,082.12
    -133.58 (-0.88%)
     
  • Russell 2000

    2,288.45
    -7.74 (-0.34%)
     
  • Gold

    1,794.60
    +12.70 (+0.71%)
     
  • EUR/USD

    1.1635
    +0.0004 (+0.0349%)
     
  • 10-Yr Bond

    1.6570
    -0.0190 (-1.13%)
     
  • Vix

    15.57
    +0.56 (+3.73%)
     
  • GBP/USD

    1.3745
    -0.0051 (-0.3697%)
     
  • USD/JPY

    113.4620
    -0.5260 (-0.4615%)
     
  • BTC-USD

    60,668.39
    -1,980.29 (-3.16%)
     
  • CMC Crypto 200

    1,447.77
    -55.27 (-3.68%)
     
  • FTSE 100

    7,204.55
    +14.25 (+0.20%)
     
  • Nikkei 225

    28,804.85
    +96.27 (+0.34%)
     

5 COVID Vaccine Stocks With Late-Stage Candidates You'll Want to Watch

·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

More COVID-19 vaccines could be on the way. While hundreds of millions of people around the world have received shots from the vaccines that are already approved or authorized, several other vaccine candidates are currently in late-stage testing. In this Motley Fool Live video, recorded on Sept. 8, Fool contributors Keith Speights and Brian Orelli discuss five stocks to watch that could be winners if those late-stage clinical trials are successful.